Skip to main content
Merck KGaA logo

Merck KGaA — Investor Relations & Filings

ISIN · DE0006599905 LEI · 529900OAREIS0MOPTW25 Manufacturing
Open in API
Filings indexed 130 across all filing types
Latest filing 2026-05-21 Major Shareholding Noti…
Country DE Germany
Listing —

About Merck KGaA

https://www.merckgroup.com/

Merck KGaA is a global science and technology company operating through three primary business sectors: Healthcare, Life Science, and Electronics. The Healthcare division focuses on discovering, developing, and manufacturing prescription medicines for conditions such as oncology, multiple sclerosis, and infertility. The Life Science business provides researchers with laboratory tools, technologies, and services to facilitate scientific breakthroughs and biopharmaceutical manufacturing. The Electronics sector develops high-tech materials and solutions for the semiconductor and display industries. Driven by a long history of innovation, the company integrates specialized expertise to address complex global challenges, offering a diverse portfolio of products ranging from life-saving therapies to advanced materials that power modern digital infrastructure.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 96% confidence The document header and content constitute a ‘Notification of Major Holdings’ under Article 40 of the German Securities Trading Act (WpHG). It reports on threshold crossings, voting rights percentages, and detailed shareholding structures – a classic major shareholding notification. Therefore, it fits the Major Shareholding Notification category (MRQ).
2026-05-21 English
Q1 statement / Q1 financial report 2026
Earnings Release Classification · 85% confidence The document is a Merck news release dated May 13, 2026 that summarizes first-quarter financial results (net sales, EBITDA pre, EPS pre) and upgrades full-year guidance. It presents key highlights and management commentary but does not include full financial statements or detailed analysis typical of an Interim/Quarterly Report. This matches the definition of an Earnings Release (ER). Q1 2026
2026-05-20 English
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 90% confidence The document is a regulatory announcement under Article 40 of the German Securities Trading Act (WpHG) disclosing a change in major shareholding by BlackRock in Merck KGaA, including threshold crossing and detailed holding percentages. This fits the definition of a Major Shareholding Notification (notification of changes in significant share ownership levels).
2026-05-14 English
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 94% confidence The document is a detailed Voting Rights Announcement under Article 40 of the German Securities Trading Act (WpHG) disclosing threshold crossings and major holdings by BlackRock in Merck KGaA. This is a notification of changes in significant share ownership levels, matching the "Major Shareholding Notification" category (MRQ).
2026-05-13 English
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 99% confidence The document is a German ’Stimmrechtsmitteilung’ under § 40 WpHG disclosing a threshold crossing in voting rights (from 2.28% to 3.29%). This is a notification of a change in significant share ownership levels, matching the Major Shareholding Notification category.
2026-05-12 German
Regulatory Filings 2026
Regulatory Filings
2026-05-04 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.